- Home
- RPID vs PASG Comparison
RPID vs PASG Comparison
Compare RPID & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- PASG
- Stock Information
- Founded
- RPID 2006
- PASG 2017
- Country
- RPID United States
- PASG United States
- Employees
- RPID N/A
- PASG N/A
- Industry
- RPID Medical Specialities
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- RPID Health Care
- PASG Health Care
- Exchange
- RPID Nasdaq
- PASG Nasdaq
- Market Cap
- RPID 43.5M
- PASG 42.2M
- IPO Year
- RPID 2021
- PASG 2020
- Fundamental
- Price
- RPID $1.23
- PASG $0.60
- Analyst Decision
- RPID
- PASG Strong Buy
- Analyst Count
- RPID 0
- PASG 3
- Target Price
- RPID N/A
- PASG $8.00
- AVG Volume (30 Days)
- RPID 144.4K
- PASG 886.7K
- Earning Date
- RPID 02-28-2025
- PASG 03-03-2025
- Dividend Yield
- RPID N/A
- PASG N/A
- EPS Growth
- RPID N/A
- PASG N/A
- EPS
- RPID N/A
- PASG N/A
- Revenue
- RPID $26,170,000.00
- PASG N/A
- Revenue This Year
- RPID $24.34
- PASG N/A
- Revenue Next Year
- RPID $19.49
- PASG N/A
- P/E Ratio
- RPID N/A
- PASG N/A
- Revenue Growth
- RPID 27.31
- PASG N/A
- 52 Week Low
- RPID $0.58
- PASG $0.45
- 52 Week High
- RPID $1.45
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- RPID 65.59
- PASG 43.68
- Support Level
- RPID $1.00
- PASG $0.56
- Resistance Level
- RPID $1.37
- PASG $0.64
- Average True Range (ATR)
- RPID 0.12
- PASG 0.11
- MACD
- RPID 0.03
- PASG -0.01
- Stochastic Oscillator
- RPID 62.07
- PASG 8.69
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.